Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
  • Physician-Scientist Development
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • In-Press Preview
    • Resource and Technical Advances
    • Clinical Research and Public Health
    • Research Letters
    • Editorials
    • Perspectives
    • Physician-Scientist Development
    • Reviews
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • In-Press Preview
  • Resource and Technical Advances
  • Clinical Research and Public Health
  • Research Letters
  • Editorials
  • Perspectives
  • Physician-Scientist Development
  • Reviews
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
14-3-3ζ Constrains insulin secretion by regulating mitochondrial function in pancreatic β cells
Yves Mugabo, Cheng Zhao, Ju Jing Tan, Anindya Ghosh, Scott A. Campbell, Evgenia Fadzeyeva, Frédéric Paré, Siew Siew Pan, Maria Galipeau, Julia Ast, Johannes Broichhagen, David J. Hodson, Erin E. Mulvihill, Sophie Petropoulos, Gareth E. Lim
Yves Mugabo, Cheng Zhao, Ju Jing Tan, Anindya Ghosh, Scott A. Campbell, Evgenia Fadzeyeva, Frédéric Paré, Siew Siew Pan, Maria Galipeau, Julia Ast, Johannes Broichhagen, David J. Hodson, Erin E. Mulvihill, Sophie Petropoulos, Gareth E. Lim
View: Text | PDF
Research Article Endocrinology Metabolism

14-3-3ζ Constrains insulin secretion by regulating mitochondrial function in pancreatic β cells

  • Text
  • PDF
Abstract

While critical for neurotransmitter synthesis, 14-3-3 proteins are often assumed to have redundant functions due to their ubiquitous expression, but despite this assumption, various 14-3-3 isoforms have been implicated in regulating metabolism. We previously reported contributions of 14-3-3ζ in β cell function, but these studies were performed in tumor-derived MIN6 cells and systemic KO mice. To further characterize the regulatory roles of 14-3-3ζ in β cell function, we generated β cell–specific 14-3-3ζ–KO mice. Although no effects on β cell mass were detected, potentiated glucose-stimulated insulin secretion (GSIS), mitochondrial function, and ATP synthesis were observed. Deletion of 14-3-3ζ also altered the β cell transcriptome, as genes associated with mitochondrial respiration and oxidative phosphorylation were upregulated. Acute 14-3-3 protein inhibition in mouse and human islets recapitulated the enhancements in GSIS and mitochondrial function, suggesting that 14-3-3ζ is the critical isoform in β cells. In dysfunctional db/db islets and human islets from type 2 diabetic donors, expression of Ywhaz/YWHAZ, the gene encoding 14-3-3ζ, was inversely associated with insulin secretion, and pan–14-3-3 protein inhibition led to enhanced GSIS and mitochondrial function. Taken together, this study demonstrates important regulatory functions of 14-3-3ζ in the regulation of β cell function and provides a deeper understanding of how insulin secretion is controlled in β cells.

Authors

Yves Mugabo, Cheng Zhao, Ju Jing Tan, Anindya Ghosh, Scott A. Campbell, Evgenia Fadzeyeva, Frédéric Paré, Siew Siew Pan, Maria Galipeau, Julia Ast, Johannes Broichhagen, David J. Hodson, Erin E. Mulvihill, Sophie Petropoulos, Gareth E. Lim

×

Figure 8

Inhibition of 14-3-3 proteins improves insulin secretory capacity and mitochondrial function in human islets from T2D donors.

Options: View larger image (or click on image) Download as PowerPoint
Inhibition of 14-3-3 proteins improves insulin secretory capacity and mi...
(A) Isolated mRNA from islets from normal, obese, and T2D human donors were subjected to qPCR analysis for 14-3-3 isoform expression (n = 3-5 donors per group; *P < 0.05 when compared with normal donor). (B and C) Human T2D islets (n = 3 donors) were treated with pan–14-3-3 inhibitors (10 μM each) for 2 hours, and a potentiation of glucose-stimulated insulin secretion was observed (B); no differences in total insulin content (TIC) were detected (C). (D) qPCR was used to measure changes in mRNA levels of PDX1, MAFA, BETA2, GLUT1, GLUT3, INS, GCG, and NKX6 after 72 hours of treatment with 14-3-3 inhibitors (10 μM each). (E–G) T2D human islets were treated with pan–14-3-3 protein inhibitors (10 μM each) or DMSO followed by Seahorse Extracellular Flux analysis to examine mitochondrial function, as determined by OCR (E and F) and ATP-link oxygen consumption (G). For OCR trace: (line A) glucose (16 mM); (line B) oligomycin (5 μM); (line C) FCCP (1μM); and (line D) rotenone/antimycin (5μM). (H) ATP content in T2D human islets was measured after exposure to 14-3-3 inhibitors (10 μM each) and different glucose concentrations (n = 3 donors; *P < 0.05 when compared with DMSO). Significance was determined by 1-way ANOVA with Dunnett’s test (A, D, F, and G) or by 2-way ANOVA, followed by Tukey’s multiple-comparison tests (B and H).

Copyright © 2026 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts